The FDA has approved Blujepa for the treatment of uncomplicated urogenital gonorrhea caused by susceptible strains of Neisseria gonorrhoeae.

Trauma severity predicted SSI risk and ertapenem prophylaxis reduced traumatic wound infection rates following exploratory laparotomy for visceral perforation.

COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.

A system-level, multifactorial intervention significantly reduced the risk of maternal infection outcomes, according to a recent study.

Elevated lactate levels and hypotension independently predicted higher in-hospital mortality in critically ill adults with COVID-19.

Ablation therapy demonstrated comparable effectiveness for HCC in patients with hepatitis B-related recompensated vs compensated cirrhosis.

Racial and ethnic disparities in pediatric COVID-19 severity were largest among hospitalized Black and Hispanic children with CCCs or government insurance.

Early measles vaccination rates among infants aged 6 to 11 months in Texas increased sharply during the 2025 measles outbreak, suggesting families and clinicians responded to the updated CDC ...

HCC risk remains after DAA-cured HCV in individuals with HIV, but the annual probability of developing HCC declines over 6 years.

Real-world evidence reinforces the effectiveness of nirsevimab in preventing severe respiratory syncytial virus-associated outcomes including intensive care unit admission and acute respiratory ...

The higher prevalence of anti-tuberculosis drug-induced liver injury in patients with vs without hepatitis C virus (HCV) coinfection highlights the importance of routine HCV screening prior to ...

Cuba’s deputy health minister said that 33 people have died from chikungunya and dengue since July; 21 of the deaths were in children. HealthDay News — A severe mosquito-borne virus outbreak in Cuba ...